Suppr超能文献

5分割再程立体定向放射治疗肺腺癌脑转移瘤8分割立体定向放射治疗后进展:生物等效剂量≥80 Gy的大体肿瘤覆盖及内剂量增加的重要性

5-Fraction Re-radiosurgery for Progression Following 8-Fraction Radiosurgery of Brain Metastases From Lung Adenocarcinoma: Importance of Gross Tumor Coverage With Biologically Effective Dose ≥80 Gy and Internal Dose Increase.

作者信息

Ohtakara Kazuhiro, Tanahashi Kuniaki, Kamomae Takeshi, Suzuki Kojiro

机构信息

Department of Radiation Oncology, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, JPN.

Department of Radiology, Aichi Medical University, Nagakute, JPN.

出版信息

Cureus. 2023 Jul 22;15(7):e42299. doi: 10.7759/cureus.42299. eCollection 2023 Jul.

Abstract

The criteria for indication of salvage stereotactic radiosurgery (SRS) for local progression following multi-fraction (mf) SRS of brain metastases (BMs) remain controversial, along with the optimal planning scheme. Herein, we described a case of BMs from pan-negative lung adenocarcinoma (LAC), in which the two lesions of local progression following initial eight-fraction (8-fr) SRS were re-treated with 5-fr SRS with the biologically effective dose (BED) of ≥80 Gy, based on the linear-quadratic (LQ) formula with an alpha/beta ratio of 10. The re-SRS resulted in the alleviation of symptoms and favorable tumor responses with minimal adverse effects during the 7.3-month follow-up. In the lesions of local progression, the gross tumor volume (GTV) coverage with 49.6 Gy (BED 80 Gy) was generally insufficient, and the GTV dose wes relatively homogeneous with ≥87% isodose covering. In contrast, the 5-fr re-SRS was performed with sufficient GTV coverage with ≤68% isodose of 43 Gy (BED 80 Gy). Taken together, sufficient GTV coverage with a BED of ≥80 Gy and steep dose increase inside the GTV boundary, that is, extremely inhomogeneous GTV dose, are important in 8-fr SRS for ensuring excellent local control of BMs from pan-negative LAC. For local progression following mfSRS that does not fulfill both criteria, re-SRS with the above planning scheme can be an efficacious and safe treatment option for at least six months, especially in cases in which the prior SRS was performed with a dose/fractionation under adequate consideration of brain tolerance. The BED seems to be the most suitable for estimating the anti-tumor efficacies of SRS doses in 3-8 fr, similar to that of a single fraction of 24 Gy.

摘要

对于脑转移瘤(BMs)多分割(mf)立体定向放射外科治疗(SRS)后局部进展的挽救性SRS的指征标准,以及最佳规划方案,仍存在争议。在此,我们描述了一例来自泛阴性肺腺癌(LAC)的BMs病例,其中,基于α/β比值为10的线性二次(LQ)公式,对初始八分割(8-fr)SRS后局部进展的两个病灶采用生物等效剂量(BED)≥80 Gy的五分割SRS进行再次治疗。再次SRS导致症状缓解,在7.3个月的随访期间肿瘤反应良好且不良反应最小。在局部进展的病灶中,49.6 Gy(BED 80 Gy)的大体肿瘤体积(GTV)覆盖通常不足,且GTV剂量相对均匀,等剂量线覆盖≥87%。相比之下,五分割再次SRS在GTV覆盖充足的情况下进行,43 Gy(BED 80 Gy)的等剂量线≤68%。综上所述,对于确保泛阴性LAC的BMs获得良好的局部控制,在8分割SRS中,BED≥80 Gy的充足GTV覆盖以及GTV边界内陡峭的剂量增加,即极度不均匀的GTV剂量,非常重要。对于未满足这两个标准的mfSRS后局部进展,采用上述规划方案的再次SRS至少在六个月内可以是一种有效且安全的治疗选择,特别是在先前SRS的剂量/分割充分考虑脑耐受性的情况下。BED似乎最适合估计3 - 8分割SRS剂量的抗肿瘤疗效,类似于单次24 Gy分割的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a4/10441669/f614c8f256d9/cureus-0015-00000042299-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验